Walter Greenleaf, Ph.D., is a neuroscientist and a medical technology developer at Stanford University. With over 35 years of work developing clinical applications of medical virtual reality technology, Walter is considered a leading authority.
Dr. Greenleaf is currently a Visiting Scholar at Stanford University’s Virtual Human Interaction Lab. He also works to develop next-generation wearable sensors as part of the eWear Program at the Stanford School of Engineering. He previously served as the Director of the Mind Division at the Stanford Center on Longevity, focusing on age-related changes in cognition.
Walter was the founding Chief Science Officer for Pear Therapeutics and is the Chief Science Officer for Interaxon. In addition to his academic work, he is the technology and neuroscience advisor to several early-stage medical product companies and accelerator/incubator programs.